Zhanjun Jia Selected Research

Polyuria

1/2020	Chloroquine attenuates lithium-induced NDI and proliferation of renal collecting duct cells.
10/2016	Inhibition of mitochondrial complex-1 restores the downregulation of aquaporins in obstructive nephropathy.
12/2009	Mice lacking mPGES-1 are resistant to lithium-induced polyuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhanjun Jia Research Topics

Disease

41	Inflammation (Inflammations) 05/2023 - 02/2010
25	Acute Kidney Injury (Acute Renal Failure) 10/2023 - 01/2011
19	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2014
16	Fibrosis (Cirrhosis) 04/2024 - 12/2013
13	Chronic Renal Insufficiency 01/2024 - 09/2014
12	Ureteral Obstruction 11/2023 - 01/2014
10	Neoplasms (Cancer) 01/2023 - 12/2008
10	Kidney Diseases (Kidney Disease) 01/2020 - 01/2014
9	Hypertension (High Blood Pressure) 01/2023 - 11/2006
9	Proteinuria 01/2021 - 01/2010
8	Anemia 01/2024 - 01/2012
7	Ischemia 10/2023 - 10/2008
7	Albuminuria 06/2018 - 12/2013
6	Hypoxia (Hypoxemia) 01/2024 - 01/2018
5	Obesity 03/2023 - 01/2018
5	Body Weight (Weight, Body) 03/2023 - 07/2010
4	Sepsis (Septicemia) 03/2023 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
4	Wounds and Injuries (Trauma) 01/2018 - 12/2014
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2013
3	Reperfusion Injury 11/2023 - 10/2008
3	Bites and Stings (Sting) 01/2023 - 01/2021
3	Peritoneal Fibrosis 01/2022 - 02/2010
3	Necrosis 01/2022 - 01/2015
3	Sclerosis 01/2021 - 12/2013
3	Atherosclerosis 01/2020 - 01/2016
3	Polyuria 01/2020 - 12/2009
2	Nephrogenic Diabetes Insipidus 10/2023 - 01/2020
2	Liver Diseases (Liver Disease) 06/2023 - 01/2021
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2022
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 01/2017
2	Hyperaldosteronism (Conn Syndrome) 01/2020 - 10/2018
2	Bartter Syndrome (Syndrome, Bartter) 01/2020 - 10/2018
2	Alkalosis 01/2020 - 10/2018
2	Vascular System Injuries 05/2019 - 01/2017
2	Vascular Diseases (Vascular Disease) 11/2018 - 01/2016

Drug/Important Bio-Agent (IBA)

19	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2015
13	Dinoprostone (PGE2)FDA Link 01/2022 - 11/2008
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
9	InflammasomesIBA 01/2023 - 09/2014
9	RotenoneIBA 12/2019 - 01/2014
8	LipidsIBA 04/2024 - 01/2015
8	ProstaglandinsIBA 04/2024 - 11/2008
8	SaltsIBA 01/2019 - 11/2006
7	roxadustatIBA 12/2023 - 01/2018
7	SodiumIBA 01/2018 - 11/2006
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2023 - 01/2010
6	Prostaglandin-E SynthasesIBA 01/2021 - 12/2009
5	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 01/2018
5	Prostaglandins EIBA 01/2023 - 12/2009
5	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2022 - 01/2018
5	manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA 01/2022 - 04/2015
5	AlbuminsIBA 01/2019 - 04/2015
4	Adenosine Triphosphate (ATP)IBA 01/2022 - 06/2014
4	EnzymesIBA 01/2022 - 02/2010
4	AldosteroneIBA 07/2021 - 01/2016
4	celastrolIBA 02/2021 - 01/2018
4	Mitochondrial DNA (mtDNA)IBA 01/2021 - 06/2014
4	Angiotensin IIIBA 01/2021 - 11/2008
4	CXA-10IBA 12/2013 - 10/2008
3	Prolyl-Hydroxylase InhibitorsIBA 01/2024 - 01/2018
3	LithiumIBA 10/2023 - 12/2009
3	AcidsIBA 04/2023 - 01/2015
3	artenimol (dihydroartemisinin)IBA 03/2023 - 11/2018
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
3	Therapeutic UsesIBA 01/2022 - 01/2020
3	Pregnane X ReceptorIBA 01/2022 - 01/2020
3	CytokinesIBA 01/2022 - 02/2010
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
3	Caspase 3 (Caspase-3)IBA 01/2021 - 07/2019
3	superoxide dismutase 2IBA 01/2021 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2013
3	CollagenIBA 12/2019 - 05/2018
3	Fibronectins (Fibronectin)IBA 12/2019 - 12/2008
3	NPHS2 proteinIBA 01/2017 - 06/2014
3	nephrinIBA 01/2017 - 06/2014
3	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2015 - 02/2010
2	Insulin (Novolin)FDA Link 04/2024 - 12/2019
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2021
2	artemisinin (artemisinine)IBA 03/2023 - 01/2020
2	2- ((7- nitrobenzo(c)(1,2,5)oxadiazol- 4- yl)thio)pyridine 1-oxideIBA 03/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2021
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022 - 01/2020
2	InterleukinsIBA 01/2022 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 12/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2016
2	AntioxidantsIBA 01/2021 - 11/2008
2	Chloride Channels (Chloride Channel)IBA 01/2020 - 10/2018
2	CilomilastIBA 01/2020 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 02/2010
2	Interleukin-6 (Interleukin 6)IBA 04/2019 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 01/2018 - 01/2017
2	Aquaporins (Water Channels)IBA 01/2018 - 10/2016

Therapy/Procedure

16	Therapeutics 10/2023 - 01/2016
4	Nephrectomy 01/2021 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
3	Peritoneal Dialysis 01/2022 - 02/2010
2	Ligation 01/2021 - 01/2018